NCT03333915 2025-02-04Study of the Efficacy, Safety and Pharmacokinetics of Pamiparib (BGB-290) in Participants With Advanced Solid TumorsBeiGenePhase 1/2 Completed128 enrolled 36 charts
NCT03575065 2024-10-26Efficacy and Safety of BGB-290 in the Treatment of Metastatic HER2-Negative Breast Cancer Patients With BRCA Mutation in ChinaBeiGenePhase 2 Completed88 enrolled 17 charts